New Tool: ProSource
Check out our packaging and processing solutions finder, ProSource.

Top 10 of 2023 - #5: What Does a DSCSA Stabilization Period Mean?

Join us as we look back at the most-read Healthcare Packaging stories of 2023. At #5, FDA announced a DSCSA stabilization period through Nov. 2024 but is urging all trading partners not to take their feet off the gas.

Dscsa Stabilization Pharma Getty Images 153081592

The HDA Traceability Seminar opened with a packed house and a key message running through presentations: the DSCSA EDDS guidance that FDA dropped Friday, Aug. 25, 2023, is not to be looked at as simply enforcement discretion but as a stabilization period through Nov 27, 2024.

As FDA's Leigh Verbois said in her co-presentation with Connie Jung, “Let me just be really clear, we want to make sure that this time is used to implement, troubleshoot, and mature systems for trading partners and processes while supporting the continued availability of products. With the compliance policies in this new guidance, we want to focus on November 2023 and beyond.”  

Jung, FDA senior advisor for policy, reiterated the message. “This does not mean to stop doing anything. We want you to continue to implement, we expect you to continue to implement because if you don't, you will never get there,” she said. “Our expectation is that we want you to test and exchange electronic data before the date. This is what we were saying about November 2023—now, it's before November 2024, you need to be exchanging that data electronically.” 

While some may still view this as a pause, Tish Pahl, principal, Olsson Frank Weeda Terman Matz PC, highlighted a section of the guidance which is actually underlined in the EDDS guidance:

"This guidance is not intended to provide, and should not be viewed as providing, a justification for delaying efforts by trading partners to implement the enhanced drug distribution security requirements under section 582(g)(1) of the FD&C Act. FDA strongly urges trading partners to continue their efforts to implement necessary measures to satisfy these enhanced drug distribution security requirements."

As Pahl noted, "FDA doesn't use typographical arts in the way that others might... so the fact that they underlined this is actually really unusual and very important." She suggested that when dealing with companies that are calling up and canceling their contracts, show them this verbiage. 

Get the full story here.


List: Top 10 Healthcare Packaging stories of 2023

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub
How to Honor a Leader
Induction into the Packaging & Processing Hall of Fame is the highest honor in our industry. Submit your leader to be considered for the Class of 2024 now through June 10th. New members will be inducted at PACK EXPO International in Chicago.
Read More
How to Honor a Leader